Thierry Walzer

37PUBLICATIONS
168CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reaction engineering (excl. nuclear reactions)Cancer diagnosisInfectious diseasesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Feb 11, 2026
Dual inhibition of mTOR and calcineurin pathways mitigates missing self-induced NK cell-mediated microvascular rejection.

Sarah Hamada, Jack Beadle, Alice Koenig

|Jan 28, 2026
IRF2 deficiency disrupts pyroptosis, NK cell interferon-γ production and resistance to Francisella.

Maxence Cornut, Sophia Djebali, Elena Rondeau

|Sep 16, 2025
Interleukins 15 and 18 synergistically prime the antitumor function of natural killer cells through noncanonical activation of mTORC1.

Lucie Fallone, Kévin Pouxvielh, Laure Arbez

|Jul 09, 2025
Immunological and Clinical Markers of Post-acute Sequelae of COVID-19: Insights from Mild and Severe Cases 6 Months Post-infection.

William Mouton, Sophia Djebali, Marine Villard

|Feb 11, 2025
NK Cell Immaturity and NKp30 Expression Positively Correlate with Clinical Outcome in Multiple Myeloma Patients from the IFM2009 Clinical Trial.

Marine Villard, Sébastien Viel, Lionel Karlin

|Jan 03, 2025
Pivotal role of exogenous pyruvate in human natural killer cell metabolism.

Nicolas Kern Coquillat, Louis Picq, Ameline Hamond

Pageof 7

Frequent Collaborators

11 joint publications

Antoine Marçais

7 joint publications

Sophia Djebali

6 joint publications

Alexandre Belot

6 joint publications

Anne-Laure Mathieu